ReviewJournal of personalized medicine2020

Pharmacogenomics, Pharmacokinetics and Circulating Proteins as Biomarkers for Bevacizumab Treatment Optimization in Patients with Cancer: A Review.

Apostolos Papachristos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.